03 September 2007
Donor DNA is detected in recipient blood for years after kidney transplantation using sensitive forensic medicine methods
Joanna Rutkowska, Bożenna Interewicz, Andrzej Rydzewski, Marta Świętek, Aleksandra Dominiak, Marek Durlik, Waldemar L. OlszewskiAnn Transplant 2007; 12(3): 12-14 :: ID: 546205
Abstract
Background: Transplanted vascularized organs shed passenger cells, normal constituents of whole organs, that migrate to recipient lymphoid tissues and produce microchimerism. These cells lyzed by recipient cytotoxic cells release cellular organelles into the recipient circulation. In addition, warm and cold ischemia as well as immune rejection of the transplanted organ or tissue bring about destructive changes in the graft parenchymatous cells. The knowledge of the fate of donor DNA distributed in passenger cells and in fragments of disrupted nuclei as well as the role of recipient cells internalizing donor DNA could give some insight into the mechanism of graft destruction and immunization or tolerance to donor antigens.
Material/Methods: In this study we provide evidence that forensic medicine testing of polymorphic genes for phospholipase A2, cytochrome P450 and locus D1S80 may be useful for the detection of donor DNA microchimerism in kidney transplant recipients in sex-matched combinations as well as previous blood transfusion recipients.
Results: Donor DNA was detected in recipient whole blood even 2 years after kidney transplantation.
Conclusions: The biological signifi cance of our fi ndings is not clear. We speculate that donor DNA fragments in recipient immune cells may play a role in the immunization/ tolerance process to allogeneic antigens.
Keywords: Kidney Transplantation, donor DNA, passenger cells
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






